Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
IRISH drugmaker Shire said on Tuesday that it had offered to buy the biopharmaceutical company Baxalta in an all-stock deal worth about US$30 billion.
Shire said on Tuesday that it had approached Baxalta in early July about a potential combination, but Baxalta concluded,...